News

Recommendation based on TACKLE Phase III treatment data showing reduced risk of severe COVID-19 or death AstraZeneca's Evusheld (tixagevimab and cilgavimab, formerly…
Read More...

bluebird bio, Inc. announced the U.S. Food and Drug Administration (FDA) has granted Accelerated Approval of SKYSONA (elivaldogene autotemcel), also known as eli-cel, to slow the…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has approved the fixed-dose combination of Opdualag (nivolumab and relatlimab) for the first-line treatment of advanced…
Read More...

NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co., Ltd. announced that they have entered into a conditional exclusive license agreement for NeuroBo to develop and commercialize DA-1241…
Read More...

Caladrius Biosciences, Inc. and Cend Therapeutics, Inc. announced that the proposed merger of the two companies has closed following the approval of Caladrius’ stockholders on September…
Read More...

Gilead Sciences, Inc. announced updates to the World Health Organization’s (WHO) Therapeutics and COVID-19: living guideline, which now conditionally recommends Veklury (remdesivir) for…
Read More...

Avicanna Inc., a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce that it…
Read More...

Mallinckrodt plc announced that the U.S. Food and Drug Administration (FDA) approved Terlivaz (terlipressin) for injection. Terlivaz is the first and only FDA-approved product indicated…
Read More...

Oxford Biomedica plc announces that its subsidiary Oxford Biomedica Solutions LLC has signed an agreement with a new undisclosed, U.S. based, private biotechnology company. The…
Read More...

BriaCell Therapeutics Corp. announces that it has signed an agreement with Caris Life Sciences (Caris). “Our goal is to develop immunotherapies that are personalized for each patient,…
Read More...

The U.S. Food and Drug Administration and the National Institutes of Health (NIH) announced the launch of the Critical Path for Rare Neurodegenerative Diseases (CP-RND) – a…
Read More...

Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living medicines for chronic diseases, announced the close of a $43.5 million Series B financing. The…
Read More...

Novavax, Inc. and Serum Institute of India Pvt. Ltd. (SII) announced that the South African Health Products Regulatory Authority has granted full product registration with conditions…
Read More...

Valeo and the French Alternative Energies and Atomic Energy Commission (CEA) signed an agreement to collaborate on the next generations of power electronics, which are at the heart of…
Read More...

Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by oxidative stress, and…
Read More...

RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, announced a $160 million Series D financing co-led by…
Read More...

Syros Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to SY-5609 for the treatment of pancreatic cancer.…
Read More...

Strata Oncology, Inc. a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced expansion of its clinical collaboration with Pfizer in…
Read More...

InnoCare Pharma announced that the Company has received Investigational New Drug (IND) approval of clinical trial from the NMPA (National Medical Products Administration) for its B-cell…
Read More...

A UNIQUE WORKFLOW SOLUTION INTEGRATING A PAN-CANCER NEXT-GENERATION SEQUENCING (NGS) PANEL POWERED BY A BIOINFORMATICS SOFTWARE SUITE FOR CUSTOMIZABLE BIOLOGICAL AND CLINICAL…
Read More...